Abstract:Zhaohong Wang, 1, 2, * Hui Chen, 1, * Jingjing Chen, 1, * Zhong Hong, 1 Yi Liao, 1 Qiyu Zhang, 1, 2 Hongfei Tong 1 1 Department of Hepatobiliary Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325000, People's Republic of China; 2 Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, People's Republic of China *These authors contributed equally to this work Correspondence: Qiyu Zhang; Hongfei Tong Department of Hepatobiliary Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xueyuan W Road, Lucheng Qu, Wenzhou Shi, Zhejiang Sheng 32500, People's Republic of China Tel +86 5 778 800 2710; +86 5 778 800 2710 Email qiyuz@126.com; tonghongfei@163.com Background: Excessive expression of EGFR is closely related to tumor formation, transfer and deterioration, which has attracted much attention. EGFR overexpression may be detected in up to 90% of pancreatic tumors. However, drug resistance of EGFR inhibitors targeting treatment severely limits its clinical application. Methods: In this study, Western blotting was used to detect the expression of p-Stat3, EGFR, Bcl-2, cleaved-caspase3 and Bax. Cell apoptosis was evaluated via flow cytometry. The colon assay and MTT assay were applied for detecting the cell proliferation in vitro. The xenograft mouse model was used to examine the cell proliferation in vivo. Results: Emodin remarkably enhanced the anti-cancer effect of EGFR inhibitor on pancreatic cancer cells. In addition, emodin promoted afatinib-induced apoptosis by inhibiting the Stat3 signaling pathway. Meanwhile, siRNAs against Stat3 significantly increased the apoptosis of pancreatic cancer cells. EGFR inhibitor promoted phosphorylation of Stat3 in pancreatic cancer cells. Interestingly, emodin combined with EGFR inhibitor inhibited the proliferation of pancreatic cancer cells in vitro. The tumor xenograft mice model was further confirmed that emodin possessed a synergy anticancer effect with afatinib on pancreatic cancer cells by regulating the Stat3 expression. Conclusion: These results indicate that the combination of emodin with EGFR inhibitor is an effective therapeutic strategy to sensitize human pancreatic cancer. Keywords: pancreatic cancer, EGFR inhibitors, afatinib, Stat3

Emodin-Enhanced Arsenic-Induced Apoptosis on Esophageal Tumor Cells

Emodin Enhances Arsenic Trioxide-Induced Apoptosis Via Generation of Reactive Oxygen Species and Inhibition of Survival Signaling

[Emodin Sensitizes HeLa Cell to Arsenic Trioxide Induced Apoptosis Via the Reactive Oxygen Species-Mediated Signaling Pathways].

Anti-tumor Activity of Emodin on Human Pancreatic Cancer Cell Line BXPC-3 in Vivo

Anthraquinones Sensitize Tumor Cells to Arsenic Cytotoxicity in Vitro and in Vivo Via Reactive Oxygen Species-Mediated Dual Regulation of Apoptosis

Emodin Induces Apoptosis of Colon Cancer Cells Via Induction of Autophagy in a ROS-Dependent Manner.

Alteration of Subcellular Redox Equilibrium and the Consequent Oxidative Modification of Nuclear Factor Kappa B Are Critical for Anticancer Cytotoxicity by Emodin, A Reactive Oxygen Species-Producing Agent

Gene Expression Alteration During Redox-Dependent Enhancement of Arsenic Cytotoxicity by Emodin in HeLa Cells

Antitumor Effects of Emodin on LS1034 Human Colon Cancer Cells in Vitro and in Vivo: Roles of Apoptotic Cell Death and LS1034 Tumor Xenografts Model

Emodin Induces Apoptotic Death in Murine Myelomonocytic Leukemia WEHI-3 Cells in Vitro and Enhances Phagocytosis in Leukemia Mice in Vivo.

Emodin-provoked Oxidative Stress Induces Apoptosis in Human Colon Cancer HCT116 Cells Through a P53-Mitochondrial Apoptotic Pathway.

Emodin potentiates the anticancer effect of cisplatin on gallbladder cancer cells through the generation of reactive oxygen species and the inhibition of survivin expression.

Emodin Promotes Apoptosis of Human Endometrial Cancer Through Regulating the MAPK and PI3K/ AKT Pathways

Emodin regulates apoptotic pathway in human liver cancer cells.

Anti-Cancer Effects Of Emodin On Hepg2 Cells As Revealed By H-1 Nmr Based Metabolic Profiling

Emodin enhances cytotoxicity of chemotherapeutic drugs in prostate cancer cells: the mechanisms involve ROS-mediated suppression of multidrug resistance and hypoxia inducible factor-1.

Emodin induces ferroptosis in colorectal cancer through NCOA4-mediated ferritinophagy and NF-κb pathway inactivation

Emodin enhances sensitivity of gallbladder cancer cells to platinum drugs via glutathion depletion and MRP1 downregulation.

Emodin Induces Apoptosis of Lung Cancer Cells Through ER Stress and the TRIB3/NF-κB Pathway.

Emodin sensitizes human pancreatic cancer cells to EGFR inhibitor through suppressing Stat3 signaling pathway

Involvement of PI3K/Akt, ERK and P38 Signaling Pathways in Emodin-Mediated Extrinsic and Intrinsic Human Hepatoblastoma Cell Apoptosis